Skip to main content
. Author manuscript; available in PMC: 2023 May 31.
Published in final edited form as: J Natl Med Assoc. 2020 Apr 11;112(3):268–274. doi: 10.1016/j.jnma.2020.03.010

Table 4.

Non-cMDC versus cMDC group comparisons for whites only.

White Non-cMDC White cMDC p-value
Diagnosis to initial treatment ≤30 days 37 (63.8%) 114 (53.5%) 0.249 (C)
31–60 days 20 (34.5%) 87 (40.8%)
>60 days 1 (1.7%) 12 (5.6%)
n = 58 n = 213

Diagnosis to initial treatment ≤30 days 37 (63.8%) 114 (53.5%) 0.163 (C)
>30 days 21 (36.2%) 99 (46.5%)
n = 58 n = 213

Diagnosis to initial treatment ≤60 days 57 (98.3%) 201 (94.4%) 0.311 (F)
>60 days 1 (1.7%) 12 (5.6%)
n = 58 n = 213

Diagnosis to initial treatment, days (mean ± SD) 28.2 ± 14.8 31.4 ± 16.3 0.129 (W)
Median 26.5 30.0

Missed/cancelled appointments (mean ± SD) 4.2 ± 5.5 2.7 ± 4.8 0.010 (W)a
Median 2.5 2.0

C, chi-square test; F, Fisher’s exact test; cMDC, comprehensive multidisciplinary care; SD, standard deviation; W, Wilcoxon rank sum test.

a

Statistically significant, p < 0.05.